Silence Therapeutics reported $-26.24M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AstraZeneca USD -1.5B 5.01B Sep/2025
Autolus Therapeutics Ltd USD -82.61M 17.37M Jun/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Novartis USD -9.19B 13.87B Jun/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Silence Therapeutics USD -26.24M 3.6M Sep/2025